FRANKFURT, Jan 14 (Globe Live Media) – The head of Germany’s vaccine regulator described the success rate of AstraZeneca’s COVID-19 vaccine as excellent on Thursday, after some Australian scientists expressed skepticism about its efficacy. Speaking during an online press conference, Germany’s Paul Ehrlich Institute (PEI) president Klaus Cichutek said there had been some debate about the best pattern of vaccine use.
“Still, the efficacy is still outstanding and excellent,” he said, citing data. The AstraZeneca injection, developed in conjunction with the University of Oxford, was shown in a trial to be at least 62% effective, and the UK health regulator identified 80% efficacy under a certain pattern of administration.
That compares with an efficacy of around 95% for vaccines developed by Pfizer and its partner BioNTech, as well as Moderna.
More from Author Ben Oakley here: https://globelivemedia.com/author/ben-oakley/
Ben Oakley is the guy you can really trust when it comes to Mainstream News. Whether it is something happening at the Wall Street of New York City or inside the White House in Washington, D.C., no one can cover mainstream news like Ben. Get a daily dose of Trustworthy News by Ben Oakley, only at Globe Live Media.